Amneal Reporings $45M in New Term Loans for Refinancing
Amneal Pharmaceuticals entered into Amendment No. 3 to its Term Loan Credit Agreement, adding $45.2 million in new term loans to refinance outstanding Amendments 2 loans and make further credit facility amendments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day